Symptoms of respiratory tract infection and associated care-seeking in subjects with and without obstructive lung disease; The Tromso Study: Tromso 6. by Melbye, Hasse et al.
Melbye et al. BMC Pulmonary Medicine 2012, 12:51
http://www.biomedcentral.com/1471-2466/12/51RESEARCH ARTICLE Open AccessSymptoms of respiratory tract infection and
associated care-seeking in subjects with and
without obstructive lung disease; The Tromsø
Study: Tromsø 6
Hasse Melbye*, Lisa Joensen, Mette Bech Risør and Peder A HalvorsenAbstract
Background: Respiratory tract infections (RTIs) may be more severe in those with asthma or COPD and these
patients are more frequently in need of health care. The aim of the study was to describe the frequency of RTI
symptoms in a general adult population and how care-seeking is associated with the presence of obstructive lung
disease.
Methods: Cross-sectional data including spirometry and self-reported chronic diseases were collected among
middle-aged and elderly subjects in the Tromsø population survey (Tromsø 6). Self- reported RTI symptoms,
consultations and antibiotic use were the main outcome variables. Possible predictors of RTI symptoms were
evaluated by multivariable logistic regression.
Results: Of the 6414 subjects included, 798 (12.4%) reported RTI symptoms in the previous week. RTI symptoms
were reported less frequently by subjects aged 75 years or above, than by those younger than 55 years (OR 0.5).
Winter season (OR 1.28), current smoking (OR 1.60), low self-rated health (OR 1.26) and moderate to severe
bronchial obstruction (OR 1.51), were also statistically significant independent predictors of RTI symptoms, but these
variables did not predict RTI symptoms that had started within the previous seven days. Among subjects with RTI
symptoms, 5.1% also reported a consultation with a doctor. In those with bronchial obstruction by spirometry, who
did not report asthma or COPD, this frequency was 2.4%. Antibiotic treatment was reported by 7.4% of the
participants, among whom one third had consulted a doctor. Antibiotics were taken more frequently when asthma
or COPD was reported (13.7%), but not in subjects with bronchial obstruction who did not report these diseases
(7.2%).
Conclusions: RTI symptoms seldom led to consultation with a doctor and not even in subjects with obstructive
lung disease. This was in particular the case in subjects who did not know about their obstructive lung disease.
Strategies for early diagnosis of COPD and providing health care to subjects with such disease cannot rely on their
doctor visits due to respiratory symptoms.
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Table 1 Subjects invited to participate in the Tromsø 6
study
First visit
Age 30 – 39 10% random sample
Age 40 – 42 All residents
Age 43 – 59 40% random sample
Age 60 – 87 All residents
Attenders to the second
visit of Tromsø 4#
All residents if not included above
Second visit
Age 50 – 62 All attenders to first visit
Age 63 – 74 20% random sample of attenders to first visit
Age 75 – 84 All attenders to first visit
Attenders to the second
visit of Tromsø 4#
All attenders to first visit (in Tromsø 6)
# The whole Tromsø population aged 25 years or more were invited to Tromsø
4 in 1994, and all the attending men aged 55–74 years and the attending
women aged 50–74 years were invited to the second visit [12].
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Symptoms of possible respiratory tract infections (RTIs),
such as cough, sore throat and rhinitis are common in
the community. In the USA, 19% of an adult population
reported to have had a cough, cold or another acute ill-
ness in the previous few days [1]. In Norway 13.8% of an
elderly population reported symptoms of airway infec-
tion within the last 3 weeks [2]. Symptoms of airway in-
fection are frequent reasons for seeking health care [3],
but most subjects with a possible RTI do not visit their
family doctor. A consultation rate just below 10% was
found among women in UK aged 16–44 years with a
cold, a flu or sore throat [4], whereas 25.4% of subjects
reporting RTI in the Tecumseh study (USA) had con-
sulted a doctor [5]. Among the 22% of an adult popula-
tion who reported symptoms of RTI the last 2 weeks in
a Dutch survey, 25% visited a general practitioner (GP)
[6]. The consultation rate is higher for influenza than for
common cold [5]. During the swine flu epidemic in the
USA 2009–10, 8.1% of adults reported the “flu” in the
last 30 days; among these 40% sought health care [7].
In Sweden, consultation rates for upper RTIs (URTIs)
has shown a decline since 1999, but have remained un-
changed for influenza and lower RTI [8]. Similar findings
have been found in UK, based on patient records from
general practices [3]. The decline in consultation rate
has been explained by a more restrictive prescribing
of antibiotics teaching patients that visits to the doc-
tor are often unnecessary. The rate of prescribing
antibiotics per RTI consultation has been rather stable
in Sweden [8]. Notably in the UK, a decline in URTI
related antibiotic prescribing was observed between
1997 and 2006 [8].
While RTIs for most of us are uncomplicated events,
some may have a more severe clinical course. This is
particularly the case for patients with obstructive pul-
monary diseases [9]. Frequent exacerbations are asso-
ciated with a more rapid decrease in lung function,
reduced quality of life, and severe exacerbations often
lead to acute hospital admissions. This represents a great
burden, both for the individual and the society [10].
Such patients should probably consult a GP more fre-
quently during RTIs than those who are otherwise
healthy, as early treatment is important for a favourable
outcome [11].
The aim of this study was to describe the fre-
quency of RTI symptoms in a general population, the
proportion of people with RTI symptoms that consult
a doctor, and how often such illnesses are treated
with antibiotics. We also wanted to find out to what
degree the consultation rate and use of antibiotics
are associated with self-reported obstructive pulmon-
ary disease or reduced pulmonary function, as mea-
sured by spirometry.Methods
Subjects
The subjects studied were participants in the Tromsø
Study, a repeated epidemiological, prospective study of
health problems, symptoms and chronic diseases in the
city of Tromsø, dating back to 1974 [12]. Tromsø is a
city in the northern part of Norway with 69,000 inhabi-
tants. The sixth survey was conducted between October
2007 and December 2008, with a break in July 2008. The
Department of Community Medicine, University of
Tromsø, oversees the scientific leadership and adminis-
tration of the Tromsø Study.
Subjects invited to participate in Tromsø 6, included
all residents in some age groups and random samples of
others (Table 1) The Population Registry of Norway,
with a unique national identity number given to all citi-
zens, was the source for the invitations. The attendance
rate was 65.7%, for the first visit, and about two-thirds
of those who attended the first visit were invited to a
second visit with more extended medical examination
(Table 1), in which most of the important examinations
relating to this study took place. 7307 (91.8%) attended
this second visit.Examinations
Before attending the first visit, participants had to fill in a
questionnaire on health issues including self-rated health,
previous diseases and smoking habit. Participants report-
ing angina pectoris, myocardial infarction, cerebral stroke
or atrial fibrillation were classified as “self-reported cardio-
vascular disease”. Height and weight were measured dur-
ing the first visit. Other characteristics of the participants
are dealt with in a previous publication [13].
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questionnaire concerning recent symptoms of possible
RTI and subsequent consultations with doctors and anti-
biotic treatment was filled in:
 Have you had symptoms of the common cold, acute
bronchitis or any other symptoms of airway
infection in the previous 7 days?
 If you have had symptoms of the common cold,
acute bronchitis or any other airway infection in the
previous 7 days, how many days have passed since
this illness started?
 If you have had symptoms of the common cold,
acute bronchitis or any other airway infection the
previous 7 days, have you consulted a doctor (your
GP, a GP on-call, a respiratory physician , or “other
doctor”) for this illness?
 If you have had symptoms of the common cold,
acute bronchitis or any other airway infection in the
previous 7 days, have you taken antibiotics for this
illness?
They were also asked whether they had taken any
drugs for asthma or COPD that same day. This ques-
tionnaire was computerised and each question had to be
answered before moving to the next.
Spirometry was performed by trained technical staff with
the use of a “Sensor Medics Vmax Encore 20” spirometer,
following ATS/ERS criteria [14]. Post-bronchodilator spir-
ometry was not carried out. Norwegian reference values
were used [15]. The spirometry results were only found ac-
ceptable for analysis in subjects who expired for more than
3 seconds and with a forced expiratory volume in one sec-
ond (FEV1) >0.3 l. To avoid misclassifying subject with
normal lung function as obstructive, those with FEV1/FVC
<0.7 or FEV1<80% predicted were excluded from analysis
if expiration was not carried out with sufficient force,
defined by a peak expiratory flow (PEF)≥3 x forced expira-
tory flow when 75% of the air had been expired (FEF75).
The spirometry results were categorized according to the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) classification [9]. Due to few subjects with severe
obstruction, participants with moderate and severe ob-
struction (FEV1 <80% predicted combined with a FEV1/
forced vital capacity (FVC) ratio <0.7) were merged into
one group for the main analysis, named here as “GOLD 2–
4 spirometry”. Mild COPD was defined as FEV1/FVC <0.7
and FEV1≥ 80% predicted (GOLD 1 spirometry).
Statistical analyses
The proportion reporting recent RTI symptoms, consulta-
tions with doctors, antibiotic treatment as well as the dur-
ation of the symptoms, were analysed by characteristics of
the participants, such as smoking habit, self-reporteddiseases and spirometry results. The groups of subjects
reporting asthma or COPD (chronic bronchitis/emphy-
sema/COPD), were merged into “self-reported asthma or
COPD” in some analyses, due to the high frequency of
COPD in patients reporting asthma, and in order to focus
on differences between subjects with and without an
established diagnosis of obstructive lung disease. To con-
trol for the variation in illness duration between different
subgroups, and as an indication of the weekly incidence of
new RTI symptoms, RTI symptoms that had appeared
within the previous 7 days was also applied as outcome
variable. Differences between groups were analysed by
Chi-square, Mann–Whitney, and Jonckheere-Terpstra
tests. Gender, age, and the possible predictors of RTI in bi-
variate analysis were entered a multivariable logistic re-
gression, with self-reported RTI symptoms as outcome
variable. Similarly, variables significantly associated with
days since the symptoms started, were evaluated as pre-
dictors of illness duration by multivariable linear regres-
sion. SPSS 19.0 for Windows (IBM SPSS Statistics, USA)
was used in the statistical analyses. The Tromsø Study
complies with the Declaration of Helsinki and each sub-
ject gave written informed consent prior to participation.
The Regional Committee of Medical and Health Research
Ethics approved the study.
Results
The questionnaire concerning symptoms of possible RTI
was completed by 6414 participants, 80.6% of those
invited. Spirometry was found acceptable in 6305 subjects,
(92.8% of these expired for 6 seconds or more). There
were also missing data concerning smoking (n= 91) and
self-rated health (n= 61). The mean age was 63.7 years of
age, 57.0% were women. COPD and asthma were reported
by 5.2% and 10.0% respectively. FEV1/FVC <0.7 was
found in 1422 subjects (22.5%), in 59.6% of those who
reported COPD, in 37.3% where asthma, but not COPD,
was reported and in 19% of the remaining subjects. A total
of 413 subjects reported medication for asthma or COPD
taken on the examination day. Among these, 89% also
reported asthma or COPD, 4% belonged to the subgroup
with FEV1/FVC <0.7 who did not report asthma or
COPD, whereas 7% belonged to none of these subgroups.
Of the 6414 individuals, 798 (12.4%, 95% CI 11.8%-
13.0%) reported symptoms of RTI from within the previ-
ous seven days, with the highest rate in December
(16.9%) and the lowest rate in June (9.1%). In addition,
increased reporting of recent RTI symptoms was found
in current smokers and in those reporting reduced self-
rated health. Spirometry signs of bronchial obstruction
was strongly associated with recent RTI symptoms, also
when asthma or COPD were not reported (Table 2). Age
of 75 years or above was associated with less frequent
reporting of RTI symptoms. In multivariable logistic
Table 2 Frequency of reporting symptoms of respiratory tract infection last week by characteristics of 6414 middle-





Symptoms of RTI last week that
started within the previous 7 days
n % p-value median p-value n % p-value
All (n = 6414) 798 12 8 340 5.3
Gender
Male (n = 2754) 350 13 0.6 8 0.6 149 5.4 0.7
Female (n = 3660) 448 12 8 191 5.2
Age
<55 years (n = 1059) 141 13 0.001# 7 0.03£ 79 7.5 <0.001#
55-64 years (n = 2656) 354 13 9 138 5.2
65-74 years (n = 1752) 230 13 9 217 5.5
≥ 75 Years (n = 947) 947 8 14 123 2.7
Smoking (n = 6323)
Current (n = 1158) 214 19 <0.001# 11 0.01£ 76 6.6 0.7
Previous (n = 2955) 334 11 8 132 4.5
Never (n = 2210) 240 11 7 126 5.7
Season
Winter (November-April) (n = 3128) 425 14 0.007 9 0.2 175 5.6 0.3
Summer (May-October) (n = 3286) 373 11 8 165 5.0
Self-reported disease&
Asthma, not COPD (n = 457) 69 15 0.07 11 0.5 28 6.1 0.4
COPD, not asthma (n = 172) 25 15 0.4 14 0.09 6 3.5 0.3
Both asthma and COPD (n = 141) 22 16 0.3 12 0.5 9 6.4 0.6
Neither asthma nor COPD (n = 5578) 679 12 0.09 8 0.1 296 5.3 1.0
Cardiovascular disease (n = 1154) 134 12 0.3 12 0.02 47 4.1 0.04
Self-rated health (n = 6353)
Good/exellent (n = 3949) 449 11 0.001# 8 0.01£ 207 5.2 0.9
Neither good nor bad (n = 2057) 288 14 10 109 5.3
Bad/very bad (n = 347) 53 15 14 19 5.5
Lung function (n = 6305)
Normal/restrictive (n = 4881) 567 12 <0.001# 8 <0.001£ 267 5.5 0.2#
GOLD 1 (n = 643) 80 12 11 26 4.0
GOLD 2–4 (n = 781) 134 17 13 31 4.6
Self-reported asthma or COPD
and lung function combined (n = 6305) &
Asthma or COPD not reported, FEV1/FVC≥ 0.7 (n = 4436) 511 12 0.001 8 0.009 235 5.3 0.7
Asthma or COPD reported, FEV1/FVC≥ 0.7 (n = 445) 56 13 0.9 7 0.09 32 7.2 0.05
Asthma or COPD reported, FEV1/FVC <0.7 (n = 380) 61 16 0.03 14 <0.001 11 2.9 0.04
Asthma or COPD not reported but GOLD 1 spirometry (n = 559) 69 12 1.0 9 0.9 25 4.5 0.4
but GOLD 2–4 spirometry (n = 485) 84 17 0.001 12 0.04 26 5.4 0.9
#Chi-square linear trend.
&Subject with and without the condition are compared.
£ Jonckheere-Terpstra test.
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remained statistically significant predictors of recent RTI
symptoms (Table 3).The median number of days since the symptoms
began was 8 days. Increased number of days was asso-
ciated with age, smoking, cardiovascular disease, reduced
Table 3 Predictors of self-reported symptoms of airway infection the previous seven days (n =763), and that had
started within the previous seven days (n =319), evaluated by multivariable logistic regression in 5943 middle-aged
and elderly adults taking part in the Tromsø 6 survey
RTI symptoms previous week RTI symptoms that started within previous week
Odds ratio 95% confidence
interval
p-value Odds ratio 95% confidence
interval
p-value
Male gender 1.06 0.90 - 1.24 0.5 1.13 0.90 - 1.43 0.3
Age (years)# : 55-64 0.95 0.76 - 1.17 0.6 0.67 0.50 - 0.90 0.008
65-74 0.94 0.74 - 1.19 0.6 0.77 0.56 - 1.06 0.1
75 + 0.49 0.35 - 0.68 <0.001 0.35 0.21 - 0.57 <0.001
Smoking& : current 1.60 1.29 - 1.98 <0.001 1.12 0.82 - 1.54 0.5
previous 0.99 0.82 - 1.19 0.9 0.80 0.61 - 1.03 0.09
Self-rated health, bad , or neither good or bad 1.30 1.11 - 1.53 0.001 1.12 0.88 - 1.42 0.4
Self-reported disease: Asthma, not COPD£ 1.22 0.93 - 1.62 0.2 1.22 0.81 - 1.85 0.3
COPD, not asthma£ 0.97 0.60 - 1.55 0.9 0.72 0.29 - 1.81 0.5
Both asthma and COPD£ 1.06 0.65 - 1.64 0.8 1.33 0.63 - 2.81 0.5
Cardiovascular disease 0.91 0.73 - 1.13 0.4 0.79 0.56 - 1.12 0.2
Spirometry$ : GOLD 1 spirometry 1.08 0.83 - 1.40 0.6 0.72 0.46 - 1.13 0.2
GOLD 2–4 spirometry 1.48 1.17 - 1.87 0.001 0.89 0.60 - 1.33 0.6
Winter season 1.27 1.09 - 1.50 0.002 1.15 0.92 - 1.45 0.2
The area under curve for the two models were 0.60 (0.58-0.62) and 0.60 (0.57-0.63), respectively.
# Age 38–54 years is reference category.
& Never smoking is reference category.
£ Asthma or COPD not reported is reference category.
$ FEV1/FVC≥ 0.7 is reference category.
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When analysed by linear regression, cardiovascular dis-
ease was the only significant predictor of the duration of
illness (p = 0.04, Table 4). RTI symptoms had started
within the previous seven days in 340 patients. Such
new RTI symptoms was associated with age and absenceTable 4 Predictors of duration of illness as evaluated by
linear regression in 757 subjects reporting symptoms of
respiratory tract infection the previous week in the




Male gender 0.05 0.2
Age 0.03 0.4
Smoking: Current 0.05 0.3
previous −0.01 0.8
Self-rated health: bad or neither good or bad 0.05 0.2
Self-reported disease: Asthma, not COPD 0.06 0.1
COPD, not asthma 0.2 0.6
Asthma or COPD −0.01 0.8
Cardiovascular disease 0.08 0.04
Spirometry: GOLD 1 spirometry −0.01 0.8
GOLD 2–4 spirometry 0.01 0.7of cardiovascular disease (Table 2). In logistic regression,
age above 55 years was associated with decreased report-
ing of such new symptoms (Table 3).
A consultation with a doctor for their RTI symptoms
was reported by 41 subjects (5.1%, 95% CI 4.7% - 5.5%)),
32 of these had consulted their GP. Poor self-rated
health and a period of more than 14 days since the onset
of symptoms, were significantly associated with an
increased consultation rate (Table 5). A decreased con-
sultation rate of 2.4% was found among those with
FEV1/FVC ratio < 0.7 who did not report asthma or
COPD. Taking antibiotics was reported by 58 subjects
(7.4%, 95% CI 6.9% - 7.9%). This was found to be more
frequent among those with self-reported asthma or
COPD (13.7%) and when the symptoms had started
more than two weeks earlier, 16.6%, (Table 3). Of those
who had taken antibiotics, only one third (17 subjects)
reported to have consulted a doctor. When a doctor was
consulted, 41% were treated with antibiotics. Among the
subjects who did not consult a doctor, antibiotics were
taken significantly more frequently where asthma or
COPD was reported, in 10.2% (11 subjects), compared
to 4.7% amongst the other participants with RTI symp-
toms, p = 0.02.
Among the participants with FEV1/FVC <0.7, those
reporting asthma or COPD were more frequently ex-
Table 5 Frequency of consulting a doctor and taking antibiotics in 798 subjects reporting symptoms of respiratory
tract infection the previous week in the Tromsø 6 survey
Consulting a GP Taking antibiotics
n n % n %
All 798 41 5.1 58 7.4
Gender
Male 350 19 5.4 22 6.3
Female 448 22 4.9 36 8.0
Age
<45 years 141 4 2.8 8 5.9
55-64 years 354 20 5.6 24 6.8
65-74 years 230 14 6.1 20 8.7
≥ 75 Years 73 3 4.1 6 8.2
Smoking
Current 214 12 5.6 12 5.6
Previous 334 19 5.7 27 8.1
Never 240 10 4.2 18 7.5
Season
Winter 423 17 4.0 23 5.4£
Summer 363 24 6.4 35 9.4
Self-rated health
Good/exellent 449 17 3.8& 29 6.6
Neither good nor bad 288 19 6.6 22 7.7
Bad/very bad 53 5 9.4 7 13.5
Self-reported disease
Asthma or COPD Yes 119 9 7.6 16 13.7 #
No 679 32 4.7 42 6.3
Cardiovascular disease Yes 134 11 8.2 14 10.5
No 664 30 4.5 44 6.7
Hypertension Yes 269 14 5.2 17 6.4
No 529 27 5.1 41 7.9
Days since the symptoms started
≤ 2 weeks 593 13 2.2 25 4.3
>2 weeks 205 28 13.7μ 33 16.6μ
Lung function (n = 794)
GOLD 1 spirometry 79 5 6.3 6 7.6
GOLD 2–4 spirometry 134 5 3.7 12 9.1
FEV1/FVC≥ 0.7 567 31 5.5 40 7.1
Self-reported asthma or COPD and lung function combined
No asthma or COPD reported, FEV1/FVC≥ 0.7 511 27 5.3 32 6.3
Asthma or COPD reported, FEV1/FVC≥ 0.7 56 4 7.1 8 14.3
Asthma or COPD reported, FEV1/FVC < 0.7 61 5 8.2 8 13.1
No asthma or COPD reported, but GOLD 1 spirometry 68 3 4.4 4 5.9
No Asthma or COPD reported, but GOLD 2–4 spirometry 84 2 2.4 6 7.1
£The difference between the two groups is statistically significant, p = 0.03.
& The variation between the three groups is statistically significant (chi-square linear trend), p = 0.03.
# The difference between the two groups is statistically significant, p = 0.005.
μ The difference between the two groups is statistically significant, p < 0.001.
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who did not report asthma or COPD (Table 6).
Discussion
Symptoms of RTI in the previous week were reported by
12.4%. Somewhat higher frequencies have been found in
previous studies [1,2,6]. The relatively low frequency of
reported RTI symptoms may be explained by a low oc-
currence of influenza in Norway during the study period
(2007–2008) [16]. The mild influenza outbreak may also
explain the moderate fluctuation in the frequency of RTI
symptoms throughout the year. We found reduced fre-
quency in the elderly, as did van Duijn and coworkers
[6]. The participants who were 75 years of age or older
attributed most strongly to the reduced frequency in our
study, and a poorer recall among the eldest patients,
may possibly explain some of the age effect. Current
smoking and GOLD 2–4 spirometry were also strongly
associated with the reporting of RTI symptoms. The
main reason for this was possibly the longer duration of
symptoms in subjects who smoked or had obstructive
disease and not an increased incidence of new symp-
toms, since RTI symptoms that had started in the previ-
ous week were not over-represented in these subgroups.
Increased reporting of RTI symptoms has previously
been found in patients with severe COPD [17], but such
patients represented too small a percentage of the sub-
jects with self-reported asthma/COPD or undiagnosed
bronchial obstruction, to have had an impact on the
results.
Among the 1424 subjects with FEV1/FVC <0.7, only
380 (26.7%) reported to have asthma or COPD. This
cannot be explained by incorrect reporting of diseases,
since only 4% of those who reported taking respiratory
medicine the examination day belonged to the undiag-
nosed subgroup with bronchial obstruction. Similar fre-
quencies of undiagnosed bronchial obstruction has been









No asthma or COPD reported,
FEV1/FVC≥ 0.7 (n = 4436)
42.1 36.8 46.1
Asthma or COPD reported,
but FEV1/FVC≥ 0.7 (n = 445)
30.8 35.5 46.9
Asthma or COPD reported,
and FEV1/FVC <0.7 (n = 380)
44.4# 61.9 57.2&
Asthma or COPD not reported
but GOLD 1 (n = 559)
47.8 60.5 47.1
but GOLD 2–4 (n = 485) 55.3 57.5 45.6
# p = 0.02, & p < 0.001, £ p = 0.05: statistical significance of the differenece between t
participants with FEV1/FVC ratio <0.7 (GOLD 1–4 spirometry).study adds that subjects with undiagnosed bronchial ob-
struction with pre-bronchodilator FEV1/FVC <0.7 and
FEV1 <80% predicted, experience prolonged RTI symp-
toms, similar to subjects with an established diagnosis of
asthma or COPD.
Only 5.1% with RTI symptoms had visited a doctor.
This is a considerably lower frequency than reported in
previous studies [4-6] and may mirror the trend of
decreased consultation rates for RTI found in other
countries, such as Sweden and the UK [3,8]. The low
frequency of influenza in the study period [16] may also
have contributed to the low consultation rate. The influ-
enza virus tends to give more severe symptoms than
other respiratory viruses [21], with a high consultation
rate as a result [5,7]. We found particularly low care-
seeking in the winter season. May be people find it more
acceptable to have RTI in winter than during other
seasons?
The consultation rate among those with undiagnosed
bronchial obstruction was remarkably low, just 2.4%.
The members of this subgroup had, to a lesser degree,
given up smoking and seldom reported bad health, com-
pared to those with bronchial obstruction who reported
asthma or COPD. They may have had an increased ten-
dency to postpone health care. Health contacts are not
merely a result of individual symptom recognition. Bod-
ily sensations become symptoms only when interpreted
as such by the patient Potentially alarming symptoms
are sometimes contained in specific social situations [22]
and related to cultural values and explanations [23],
regarding what is illness and what is poor health [24]. A
low consultation rate combined with good self-rated
health, despite (although undiagnosed) bronchial ob-
struction and increased duration of RTI symptoms,
points to contextual determinants of symptom interpret-
ation and care-seeking. Reluctance to be confronted with
advice to stop smoking may, for instance, have led to a













hose who did and who did not report asthma or COPD amongst the
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care, has been suggested as a strategy for case-finding [26].
The low frequency of consulting a doctor among those
with undiagnosed bronchial obstruction in the present
study, supports that a more comprehensive approach
should be applied for early diagnosis of COPD [27].
The prescribing rate when a doctor was consulted (41%)
was as expected in Nordic countries [8,28]. The majority of
those who had taken antibiotics, did not report to have vis-
ited a doctor. A quarter of these belonged to the subgroup
with self-reported asthma or COPD, who probably had
antibiotics for self-administration at home. Some might
have contacted a doctor by phone and received a prescrip-
tion that way, whilst others may have taken residual tablets
from previous prescriptions. Self-medication with antibio-
tics occurs to a varying extent throughout Europe [29]. In
the northern and western parts it is almost impossible to
buy antibiotics directly from the pharmacy, and self-
medication from left-overs is the most likely way self-
medication occurs [29,30]. It is likely that this had hap-
pened in our study population as well.
Reducing the prescription of antibiotics is a major target
in combating the emerging resistance among human patho-
gens [28]. Still, it is important that those who actually need
antibiotics get their medication without delay. RTIs are the
main cause of exacerbations among patients with COPD [9]
and often requires treatment with antibiotics [11]. It is well
known that patients with COPD often are given prescrip-
tions for short courses of oral steroids and antibiotics for
self-administration during acute exacerbations, but the
benefit of such practice is questionable [31].Strengths and limitations
Our study had the strength of being a population based
survey with a high attendance rate, with information
obtained directly from the subjects about their symptoms
and what they actually did when symptoms occurred.
Some age groups were more strongly represented in the
study sample than others. The analyses by age groups
indicates that this selection probably had little impact on
the main results, and adjustment for age has been done in
the logistic regression. It has been shown that participants
in the Tromsø study are somewhat healthier than non-
participants, and a too low frequency of RTI symptoms
may have been found.
Post-bronchodilator spirometry was not carried out,
and all subjects with FEV1/FVC <0.7, or even GOLD 2–
4 spirometry, do not really have COPD or a combination
of asthma and COPD.
Some conditions associated with our study, may have con-
tributed to the low care-seeking rate reported. The partici-
pants were invited to an extended medical examination, and
some with RTI symptoms might have postponed a visit totheir own doctor, relying on their forthcoming medical
check-up. This statement is supported by the fact that many
of the participants expressed confidence that “everything”
had been checked when they attended. We do not have in-
formation about symptoms among the non-participants. It
is likely that some of these felt too ill to attend and might
have contacted their own doctor to a greater extent, than
those who felt well enough to participate.
Conclusions
The low frequency of care-seeking due to RTI symptoms
may reflect trends of decreasing consultation rates,
which has been registered in other countries. To reduce
unnecessary use of antibiotics, consulting rates for un-
complicated respiratory infections should be kept low,
but without scaring off those who will really benefit
from medical care. The consultation rate among subjects
with obstructive lung diseases seems to be too low, at
least among those who have not got their disease diag-
nosed. Strategies for early diagnosis of COPD and pro-
viding health care to subjects with such disease, cannot
rely on their doctor visits due to respiratory symptoms
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